JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS

Scope & Guideline

Fostering Innovation in Biomolecular Research

Introduction

Immerse yourself in the scholarly insights of JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN0739-1102
PublisherTAYLOR & FRANCIS INC
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Converge1981, from 1983 to 2024
AbbreviationJ BIOMOL STRUCT DYN / J. Biomol. Struct. Dyn.
Frequency18 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106

Aims and Scopes

The Journal of Biomolecular Structure & Dynamics focuses on the interactions and dynamics of biomolecules and their implications for biological processes and drug discovery. The journal emphasizes computational methods, experimental validation, and the integration of both approaches to explore molecular interactions and therapeutic potentials.
  1. Biomolecular Dynamics and Interactions:
    Research primarily revolves around the dynamic behavior and interactions of biomolecules, including proteins, nucleic acids, and small molecules, to understand their functional mechanisms.
  2. Computational Drug Discovery:
    The journal showcases innovative computational techniques for drug discovery, including molecular docking, molecular dynamics simulations, and virtual screening, to identify potential therapeutic agents.
  3. Natural Products and Phytochemicals:
    There is a strong emphasis on the exploration of natural products and phytochemicals as potential inhibitors or therapeutic agents against various diseases, particularly through computational methods.
  4. Multi-target Approaches:
    Research often involves multi-target strategies to enhance therapeutic efficacy, focusing on complex diseases like cancer and infectious diseases, utilizing systems biology and network pharmacology.
  5. Vaccine Development and Immunoinformatics:
    The journal includes studies on vaccine design and development using computational approaches, particularly in response to emerging viral infections like COVID-19.
Recent publications in the Journal of Biomolecular Structure & Dynamics indicate several emerging themes and trends that reflect the evolving landscape of biomolecular research. These trends highlight the journal's responsiveness to contemporary scientific challenges and its commitment to advancing knowledge in key areas.
  1. AI and Machine Learning in Drug Discovery:
    The integration of artificial intelligence and machine learning techniques in drug discovery is on the rise, showcasing a trend towards data-driven approaches that enhance predictive modeling and screening efficiency.
  2. COVID-19 Related Research:
    Research targeting SARS-CoV-2, including the development of vaccines and inhibitors, remains a significant focus, reflecting the ongoing global health impact of the pandemic.
  3. Systems Biology and Network Pharmacology:
    There is an increasing trend towards employing systems biology and network pharmacology approaches to understand complex interactions within biological systems and to identify novel therapeutic targets.
  4. Phytochemical Research and Natural Products:
    The exploration of phytochemicals and their potential therapeutic applications is gaining momentum, with more studies focusing on their molecular interactions and efficacy as drug candidates.
  5. Protein-Protein Interaction Studies:
    Research focusing on protein-protein interactions, particularly in the context of disease mechanisms and therapeutic targets, is emerging as a prominent theme, indicating a shift towards understanding molecular networks.

Declining or Waning

While the journal continues to thrive in many research areas, some themes have shown a decline in frequency or prominence in recent publications. This section outlines these waning scopes, indicating a shift in research focus.
  1. Traditional Medicinal Chemistry:
    There appears to be a waning interest in classical medicinal chemistry approaches focused solely on small molecule design, as the field increasingly shifts towards integrating computational and biological methods.
  2. Single Target Drug Discovery:
    The focus on single-target drug discovery is declining in favor of multi-target approaches that consider the complexity of biological systems and disease mechanisms.
  3. Experimental-Only Studies:
    Research papers that rely solely on experimental methods without computational backing are becoming less common, reflecting a trend towards more integrated methodologies.
  4. Basic Biochemical Studies:
    There is a noticeable decrease in the publication of basic biochemical studies that do not incorporate computational analysis, as the field evolves to prioritize interdisciplinary approaches.

Similar Journals

Chemical Biology Letters

Exploring the Synergy of Chemistry and Biology
Publisher: ScienceIn PublicationsISSN: Frequency: 1 issue/year

Chemical Biology Letters is a prominent academic journal dedicated to the evolving field of biochemistry and its applications in medical and clinical contexts. Published by ScienceIn Publications, this journal serves as a vital platform for researchers, professionals, and students alike, showcasing cutting-edge findings and innovations that drive forward our understanding of chemical interactions in biological systems. With its scope ranging from molecular biology to clinical biochemistry, Chemical Biology Letters is committed to advancing knowledge and fostering collaboration within the scientific community. Recognized for its quality, the journal is categorized in Q4 for Biochemistry and Molecular Biology fields, while achieving notably higher ranks in Medical Biochemistry, reflecting its significant contributions to the discipline. Aiming to remain accessible to a diverse audience, the journal is published in open access format, inviting researchers worldwide to explore and share invaluable insights. Established in 2014, it continues to grow in impact and relevance, paving the way for advancements in both theoretical and applied research within the realm of chemical biology.

PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS

Unlocking the Secrets of Protein Dynamics
Publisher: WILEYISSN: 0887-3585Frequency: 12 issues/year

PROTEINS - STRUCTURE FUNCTION AND BIOINFORMATICS, published by WILEY, is a leading journal in the fields of biochemistry, molecular biology, and structural biology, recognized for its significant contribution to protein research since its inception in 1986. With its impressive rankings in the Q1 category for Biochemistry and Q2 for both Molecular Biology and Structural Biology in 2023, the journal serves as an essential resource for researchers and professionals seeking to explore the intricate relationships between protein structures and their functions. The journal, based in the United States, operates without an Open Access model, ensuring a curated selection of high-quality peer-reviewed articles that drive innovation and collaboration in the scientific community. Engaging with the robust content of PROTEINS not only bolsters academic scholarship but also opens avenues for groundbreaking discoveries that are pivotal in the advancing field of bioinformatics.

BIOPHYSICAL CHEMISTRY

Innovating research at the crossroads of chemistry and biology.
Publisher: ELSEVIERISSN: 0301-4622Frequency: 12 issues/year

BIOPHYSICAL CHEMISTRY, published by Elsevier, is a prestigious journal with a long-standing tradition since its inception in 1973. This highly respected journal focuses on the intersections of biochemistry, biophysics, and organic chemistry, providing a critical platform for researchers, professionals, and students to disseminate pivotal findings in these dynamic fields. With an impressive impact factor that reflects its robust academic influence and high citation rates, it ranks within the Q2 quartile among its peers in multiple categories, indicating its significance in the scholarly community. The journal, hosted in the Netherlands, encompasses a diverse range of topics, from molecular interactions to protein folding, and serves as an essential resource for those engaged in cutting-edge research. Researchers looking to share their work with a global audience will find BIOPHYSICAL CHEMISTRY an invaluable outlet, fostering the advancement of knowledge in this crucial area of science. For more information, visit the journal's page on the Elsevier platform.

JOURNAL OF BIOMOLECULAR NMR

Innovating biochemistry with cutting-edge spectroscopy.
Publisher: SPRINGERISSN: 0925-2738Frequency: 12 issues/year

JOURNAL OF BIOMOLECULAR NMR, published by SPRINGER, is a leading academic journal dedicated to advancing the field of molecular spectroscopy, particularly in the realm of biomolecular studies. With an ISSN of 0925-2738 and an E-ISSN of 1573-5001, the journal has been consistently publishing high-quality research since its inception in 1991, and continues to do so through 2024. The journal maintains an impressive reputation within its category, achieving a Q2 ranking in Biochemistry and a Q1 ranking in Spectroscopy as of 2023, reflecting its commitment to excellence and innovation in scientific research. Notably, it ranks 26th in Scopus for Chemistry - Spectroscopy and 198th for Biochemistry, indicating its significance in the scholarly community. Although it operates under a traditional access model, the journal serves as an essential resource for researchers, professionals, and students interested in the molecular nuances of biomolecules, offering insights that drive advances in biochemistry and related disciplines.

CURRENT MEDICINAL CHEMISTRY

Illuminating Pathways in Organic Chemistry and Pharmacology.
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 0929-8673Frequency: 42 issues/year

Current Medicinal Chemistry is a leading journal published by Bentham Science Publishers Ltd, known for its rigorous focus on the multifaceted realm of medicinal chemistry. With an ISSN of 0929-8673 and E-ISSN 1875-533X, the journal plays a crucial role in disseminating high-quality research findings that bridge the gap between chemistry and health sciences. Operating from Sharjah, United Arab Emirates, it has been a prominent scholarly resource since its inception in 1994, and is expected to continue until 2024. Current Medicinal Chemistry has earned its place in the academic community with an impressive impact factor and categorization in Q1 and Q2 quartiles across various disciplines, including Organic Chemistry, Biochemistry, Drug Discovery, and Pharmacology, highlighting its substantial contribution to these fields. Notably, it ranks 24th in Organic Chemistry and is within the 88th percentile, underscoring its appeal to researchers, professionals, and students alike who are keen on exploring cutting-edge advancements in drug design and development. Although it is not an open-access journal, it provides vital content that informs and inspires innovation in medicinal chemistry, appealing to a global audience committed to enhancing human health through scientific discovery.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY

Exploring Breakthroughs in Therapeutic Strategies
Publisher: TAYLOR & FRANCIS LTDISSN: 1475-6366Frequency: 1 issue/year

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, published by Taylor & Francis Ltd, is a premier open-access journal that has been at the forefront of research in the field of medicinal chemistry since its inception in 1985. With an ISSN of 1475-6366 and an E-ISSN of 1475-6374, this journal boasts a prestigious reputation reflected in its impressive Q1 rankings across critical categories such as Drug Discovery and Pharmacology as of 2023. Situated in the United Kingdom, it plays a vital role in disseminating high-quality research that addresses the burgeoning needs of drug discovery and enzyme inhibition methodologies. The journal supports full open access, providing a platform for researchers, professionals, and students to share significant findings and innovations widely. With a robust impact factor, the JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY is indispensable for any academic or professional involved in the pharmacological sciences, offering an unparalleled insight into the latest advancements in therapeutic strategies and drug development.

AIMS Molecular Science

Connecting Ideas, Inspiring Innovations in Molecular Science
Publisher: AMER INST MATHEMATICAL SCIENCES-AIMSISSN: 2372-0301Frequency: 4 issues/year

AIMS Molecular Science is a premier open-access journal published by the American Institute of Mathematical Sciences (AIMS), dedicated to the advancement and dissemination of high-quality research in the field of molecular science. Since its inception in 2014, this journal has established itself as a vital platform for researchers and professionals aiming to share their findings in molecular biology, chemistry, and interdisciplinary studies related to these domains. With an increasing focus on the accessibility of scientific knowledge, AIMS Molecular Science supports the open-access movement, ensuring that all published articles are freely available to the global research community. The journal emphasizes originality and significance in research, promoting innovative scientific methodologies and applications. By fostering collaboration and dialogue among scientists, AIMS Molecular Science plays a crucial role in advancing understanding and stimulating progress in molecular sciences.

JOURNAL OF STRUCTURAL BIOLOGY

Unveiling the Mysteries of Biological Macromolecules
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCEISSN: 1047-8477Frequency: 12 issues/year

JOURNAL OF STRUCTURAL BIOLOGY, published by Academic Press Inc. Elsevier Science, is a prestigious peer-reviewed journal dedicated to advancing the field of structural biology. With an impressive Impact Factor and recognized as a Q1 journal in its category for 2023, it holds a significant position in the academic community, ranked 20th out of 49 in the Scopus Biochemistry, Genetics and Molecular Biology - Structural Biology category. The journal publishes groundbreaking research that contributes to our understanding of biological macromolecules and their complexes, span from 1990 and continuing through 2024. Researchers and professionals alike rely on this journal for high-quality articles that cover a wide array of techniques including X-ray crystallography, NMR spectroscopy, and cryo-electron microscopy. Although it does not operate under an Open Access model, the journal remains a vital resource for those in academia and industry searching for the latest findings and methodologies in structural biology.

JOURNAL OF MOLECULAR RECOGNITION

Exploring the Depths of Molecular Recognition
Publisher: WILEYISSN: 0952-3499Frequency: 12 issues/year

JOURNAL OF MOLECULAR RECOGNITION, published by Wiley, is an esteemed academic journal that has been at the forefront of molecular biology and structural biology research since its inception in 1988. With its ISSN 0952-3499 and E-ISSN 1099-1352, this journal serves as a vital platform for disseminating innovative studies and findings in the realms of biochemical interactions and molecular structure elucidation. Although currently positioned in Quartile 4 of both molecular and structural biology categories based on 2023 metrics, the journal is dedicated to advancing knowledge in quantitative and qualitative molecular recognition processes. Researchers, professionals, and students alike will find that this journal is instrumental in keeping abreast of cutting-edge developments in the field, even as it continues to build its impact and reputation within the dynamic research landscape. Located in the United Kingdom, it is committed to promoting a diverse range of studies that drive forward the understanding of molecular interaction phenomena, thus empowering its readership to contribute effectively to the field.

Doklady Biochemistry and Biophysics

Unveiling the Complexities of Biological Systems Through Rigorous Research
Publisher: MAIK NAUKA/INTERPERIODICA/SPRINGERISSN: 1607-6729Frequency: 6 issues/year

Doklady Biochemistry and Biophysics is a vital resource for the advancement of knowledge in the fields of biochemistry and biophysics, published by MAIK NAUKA/INTERPERIODICA/SPRINGER. Featuring an ISSN of 1607-6729 and an E-ISSN of 1608-3091, this journal plays a critical role in disseminating research findings and fostering scholarly discourse. Despite its recent ranking in the Q4 quartile for biochemistry and biophysics in 2023, it serves as an essential platform for researchers exploring these intertwined disciplines. The journal’s scope encompasses a wide variety of topics, enhancing the understanding of biochemical processes and physical principles in biological systems. With converged years of publication from 2001 to 2024, it stands as a continual source of knowledge for its readers, who include researchers, professionals, and students alike. While the journal currently does not offer open access options, its contributions remain significant within the scholarly community, illustrated by its competitive Scopus rankings across related fields.